Skip to main content

Achieve Life Sciences Inc(ACHV-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update

Globe Newswire - Thu May 12, 2022

SEATTLE and VANCOUVER, British Columbia, May 12, 2022 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced first quarter 2022 financial results and provided an update on the cytisinicline clinical development program.


Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.